NICE has recommended insulin pump therapy as one option for people with type 1 diabetes provided that:
* multiple-dose insulin therapy (including using insulin glargine when it?s appropriate) has failed, and
* they are willing and able to use insulin pump therapy effectively.
NICE considers that multiple-dose insulin therapy has failed when someone has been carefully trying to manage their diabetes but hasn't been able to keep their blood glucose levels within recommended levels without having ‘disabling hypoglycaemia'. This means that they have repeated and unpredictable hypoglycaemic episodes for which they need help from other people, and which make them anxious about the episodes occurring again and significantly spoil their way of life.